Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
CureVac: Latest GBM Data Bodes Well For Next Program Check Point
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
GSK Nears $1 Billion Deal for Biotech Company IDRx
GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British ...
BioPharma Dive12h
FDA adds warning to RSV shots from GSK, Pfizer
Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.
Moderna stock on track for 10% weekly gain after US bird flu death
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
newtelegraphng1d
Delisting: Why High Profile Companies Exit NGX
ShareThe recent wave of delistings from the Nigerian Exchange (NGX) by notable companies such as Flour Mills of Nigeria (FMN) and GlaxoSmithKline (GSK) has sparked conversations among investors, ...
EurekAlert!1d
CCM Biosciences scientists report discovery of first-in-class longevity therapeutics
Compounds that enhance enzyme activity show promise for cellular rejuvenation and treating age-related diseases. However, ...
Former Hermès CEO Joins Macy’s Board As The Company Juggles Store Closures, Financial Scandal
Macy’s Inc. has appointed Robert Chavez, former Hermes Americas CEO, to the board. He faces challenges influencing strategy ...
Wayne biotech firm received $67.5 million investment to test gene therapy for heart disease
The company is trying to develop a one-time treatment for forms of heart disease that afflict more than 1 million people in ...